Prediction of an HLA-DR-binding peptide derived from Wilms’ tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124–138)-pulsed dendritic cells generated according to an optimised protocolAshley Knights, Ludmila Müller, Angeliki Zaniou et al.|Cancer Immunology Immunotherapy|2002Cited by 37
Synthetic peptides derived from the Wilms' tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cellsLudmila Müller, Graham Pawelec, Ashley Knights|The Hematology Journal|2003Cited by 25